In the case of a private company, they would be essentially providing us completely proprietary information that they wouldn't release to anyone, particularly to anyone who would be a competitor. We would hold that in our records because we have to undertake due diligence on the file. In such cases, of course, obviously, we ensure we have clearance when we do include information that they've provided us, particularly with respect to the benefit reports or how far along they are in their R and D. Each of these things could well be a sensitivity in respect of other companies that are also pursuing similar lines of R and D activity. They're all trying to aim at selling their products.
Our agreements allow us to have access to information that the companies would have, but not necessarily to release it publicly. Of course, we ensure that we have clearance from them before we aggregate it or consolidate it, in order to balance that with the need for us to explain to Canadians what we're doing with the funds we're investing. So there is a trade-off that has to be taken into account.